Sai Parenteral IPO Subscribed 1.05 Times on Day 3; GMP Flat

• Sai Parenteral's IPO subscribed 1.05 times on the third day of share sale.
• The company received bids for 61.84 lakh shares against 78.80 lakh shares on offer.
• Non-institutional investors subscribed 2.36 times, QIBs 1.71 times, and RIIs 12 percent.
• The company raised over Rs 122 crore from anchor investors.
• Proceeds will fund expansion, strengthening global formulations and CDMO capabilities.

Key Questions Answered

What factors influence an IPO's grey market premium after subscription?

Subscription levels and investor demand influence an IPO's grey market premium.

How does QIB subscription impact an IPO's long-term stock performance?

Based on the provided sources, there is no information detailing how QIB subscription impacts an IPO's long-term stock performance.

What are the risks of investing in an IPO with low retail investor interest?

Low retail investor interest in an IPO can lead to muted listing sentiment and a slipping grey market premium (GMP). This indicates a weaker demand in the unlisted market.